These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 173653)

  • 1. Passive immunization in experimental Herpesvirus hominis infection of newborn mice.
    Luyet F; Samra D; Soneji A; Marks MI
    Infect Immun; 1975 Dec; 12(6):1258-61. PubMed ID: 173653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latent herpesvirus hominis type 1 infection in the mother and passive acquired immunity in the newborn infant].
    Bujko-Klisura M; Sulović V; Marković L; Dotlić R
    Jugosl Ginekol Opstet; 1983; 23(3-4):55-7. PubMed ID: 6319834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect hemagglutinating antibody response to Herpesvirus hominis types 1 and 2 in immunized laboratory animals and in natural infections of man.
    Back AF; Schmidt NJ
    Appl Microbiol; 1974 Sep; 28(3):392-9. PubMed ID: 4371513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typing Herpesvirus hominis antibodies and isolates by inhibition of the indirect hemagglutination reaction.
    Back AF; Schmidt NJ
    Appl Microbiol; 1974 Sep; 28(3):400-5. PubMed ID: 4371294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of antibodies to Herpesvirus hominis by indirect immunofluorescent antibody method.
    Cho CT; Feng KK; Liu C
    Microsc Acta; 1977 Jan; 79(1):47-54. PubMed ID: 190522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 7. Techniques for typing Herpesvirus hominis antibody: a comparison of inhibition of peroxidase-labelled antibody staining with inhibition of indirect haemagglutination and with microneutralisation.
    Gerna G; Chambers RW
    J Med Microbiol; 1977 Aug; 10(3):309-16. PubMed ID: 197239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of human cytomegalovirus and herpesvirus hominis IgM antibody by the immunoperoxidase technique.
    Gerna G; Chambers RW
    Intervirology; 1977; 8(5):257-71. PubMed ID: 195911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.
    Oakes JE
    Infect Immun; 1975 Jul; 12(1):166-72. PubMed ID: 166926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.
    Oakes JE; Rosemond-Hornbeak H
    Infect Immun; 1978 Aug; 21(2):489-95. PubMed ID: 689732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of newborn mice against herpes simplex virus infection by prenatal and postnatal transmission of antibody.
    Hayashi Y; Wada T; Mori R
    J Gen Virol; 1983 May; 64(Pt 5):1007-12. PubMed ID: 6842184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological studies on possible causes of intra-uterine infections in Thai infants.
    Tantivanich S; Savanat T; Vongsthongsri U; Manesuwan P
    Southeast Asian J Trop Med Public Health; 1980 Sep; 11(3):387-94. PubMed ID: 6255610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative role of transplacental and milk immune transfer in protection against lethal neonatal herpes simplex virus infection in mice.
    Kohl S; Loo LS
    J Infect Dis; 1984 Jan; 149(1):38-42. PubMed ID: 6319505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to Herpesvirus hominis.
    Cho CT; Feng KK; Brahmacupta N
    J Infect Dis; 1976 Feb; 133(2):157-67. PubMed ID: 173763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental genital infection of cebus monkeys with oral and genital isolates of Herpesvirus hominis types 1 and 2.
    Felsburg PJ; Heberling RL; Kalter SS
    Arch Gesamte Virusforsch; 1972; 39(1):223-7. PubMed ID: 4344143
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation of herpesvirus hominis type II to carcinoma of the cervix. An animal model for the induction of long-term latency of herpesvirus hominis type II.
    Tobin SM; Wilson WD; Fish EN; Papsin FR
    Obstet Gynecol; 1978 Jun; 51(6):707-12. PubMed ID: 208035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.
    Kern ER; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1975 Jun; 7(6):793-800. PubMed ID: 1155920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ribavirin on Type 2 Herpesvirus hominis (HVH/2) in vitro and in vivo.
    Allen LB; Wolf SM; Hintz CJ; Huffman JH; Sidwell RW
    Ann N Y Acad Sci; 1977 Mar; 284():247-53. PubMed ID: 212976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
    Mannini-Palenzona A; Costanzo F; Cassai E; Campana G
    New Microbiol; 1993 Jul; 16(3):205-13. PubMed ID: 8396193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2.
    Asher LV; Walz MA; Notkins AL
    Am J Obstet Gynecol; 1978 Aug; 131(7):788-91. PubMed ID: 210669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.